Literature DB >> 2285617

Cardiac effects of angiotensin converting enzyme inhibitors.

N Sharpe1.   

Abstract

ACE inhibitors have provided a major advance in cardiovascular therapeutics. The rationale for their use in hypertension and heart failure, and their cardiac effects are well documented. Further information is required on the relevance of their direct myocardial and other tissue effects, and it is likely that their use in hypertension and heart failure will increase further over the next several years.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2285617     DOI: 10.1007/bf01857639

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  36 in total

1.  Treatment of patients with symptomless left ventricular dysfunction after myocardial infarction.

Authors:  N Sharpe; J Murphy; H Smith; S Hannan
Journal:  Lancet       Date:  1988-02-06       Impact factor: 79.321

2.  Evaluation of a long-acting converting enzyme inhibitor (enalapril) for the treatment of chronic congestive heart failure.

Authors:  R J Cody; A B Covit; G L Schaer; J H Laragh
Journal:  J Am Coll Cardiol       Date:  1983-04       Impact factor: 24.094

3.  Hemodynamic patterns of response during long-term captopril therapy for severe chronic heart failure.

Authors:  M Packer; N Medina; M Yushak; J Meller
Journal:  Circulation       Date:  1983-10       Impact factor: 29.690

Review 4.  Medical intelligence drug therapy: captopril.

Authors:  D G Vidt; E L Bravo; F M Fouad
Journal:  N Engl J Med       Date:  1982-01-28       Impact factor: 91.245

5.  Hemodynamic and volume changes associated with captopril.

Authors:  R C Tarazi; E L Bravo; F M Fouad; P Omvik; R J Cody
Journal:  Hypertension       Date:  1980 Jul-Aug       Impact factor: 10.190

Review 6.  Implications of local angiotensin production in cardiovascular physiology and pharmacology.

Authors:  V J Dzau
Journal:  Am J Cardiol       Date:  1987-01-23       Impact factor: 2.778

7.  Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction.

Authors:  H D White; R M Norris; M A Brown; P W Brandt; R M Whitlock; C J Wild
Journal:  Circulation       Date:  1987-07       Impact factor: 29.690

8.  Coronary hemodynamic effects of angiotensin inhibition by captopril and teprotide in patients with congestive heart failure.

Authors:  J L Halperin; D P Faxon; M A Creager; T A Bass; C D Melidossian; H Gavras; T J Ryan
Journal:  Am J Cardiol       Date:  1982-11       Impact factor: 2.778

9.  The effect of enalapril on baroreceptor mediated reflex function in normotensive subjects.

Authors:  J F Giudicelli; A Berdeaux; A Edouard; C Richer; D Jacolot
Journal:  Br J Clin Pharmacol       Date:  1985-09       Impact factor: 4.335

10.  Contrasting hemodynamic responses in severe heart failure: comparison of captopril and other vasodilator drugs.

Authors:  M Packer; N Medina; M Yushak
Journal:  Am Heart J       Date:  1982-11       Impact factor: 4.749

View more
  1 in total

Review 1.  Pharmacokinetic optimisation of angiotensin converting enzyme (ACE) inhibitor therapy.

Authors:  M Burnier; J Biollaz
Journal:  Clin Pharmacokinet       Date:  1992-05       Impact factor: 6.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.